COMMENTARY ON THE MANAGEMENT OF TREATMENT-RESISTANT AFFECTIVE-DISORDER - CLINICAL PERSPECTIVES

被引：0
|
作者：
POTTER, WZ [1 ]
MANJI, HK [1 ]
机构：
[1] NIMH, EXPTL BRANCH, CLIN PHARMACOL SECT, BETHESDA, MD 20892 USA
来源：
JOURNAL OF PSYCHOPHARMACOLOGY | 1992年 / 6卷 / 02期
关键词：
AFFECTIVE DISORDERS; TREATMENT-RESISTANT; DIAGNOSIS; COMMENTARY;
D O I：
10.1177/026988119200600207
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：164 / 166
页数：3
相关论文
共 50 条
  • [31] Treatment-resistant Obsessive-compulsive Disorder in Young People: Assessment and Treatment Strategies
    Krebs, Georgina
    Heyman, Isobel
    CHILD AND ADOLESCENT MENTAL HEALTH, 2010, 15 (01) : 2 - 11
  • [32] Sevoflurane augmentation in treatment-resistant depression: a clinical case study
    Wang, Shikai
    Cheng, Shanfei
    Feng, Min
    Guo, Ping
    Qian, Mincai
    Shen, Xinhua
    Chen, Runsen
    Wang, Gang
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2020, 10
  • [33] Treatment patterns in patients with treatment-resistant depression in Danish patients with major depressive disorder
    Gronemann, Frederikke Hordam
    Petersen, Janne
    Alulis, Sarah
    Jensen, Kristoffer Jarlov
    Riise, Jesper
    Ankarfeldt, Mikkel Zollner
    Solem, Espen Jimenez
    Bodker, Nikolaj
    Osler, Merete
    JOURNAL OF AFFECTIVE DISORDERS, 2021, 287 : 204 - 213
  • [34] Clinical Predictors of Placebo Response in Treatment-Resistant Major Depression
    Yazdian, Aaron L.
    Park, Lawrence
    Luckenbaugh, David A.
    Niciu, Mark J.
    Lener, Marc
    Nugent, Allison C.
    Ballard, Elizabeth D.
    Brutsche, Nancy E.
    Zarate, Carlos A.
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 260S - 260S
  • [35] The efficacy of nefazodone augmentation for treatment-resistant depression with anxiety symptoms or anxiety disorder
    Taylor, FB
    Prather, MR
    DEPRESSION AND ANXIETY, 2003, 18 (02) : 83 - 88
  • [36] Treatment-resistant major depressive disorder: Canadian expert consensus on definition and assessment
    Rybak, Yuri E.
    Lai, Ka S. P.
    Ramasubbu, Rajamannar
    Blumberger, Daniel M.
    Chan, Peter
    Delva, Nicholas
    Giacobbe, Peter
    Gosselin, Caroline
    Kennedy, Sidney H.
    Iskandar, Hani
    McInerney, Shane
    Ravitz, Paula
    Sharma, Verinder
    Zaretsky, Ari
    Burhan, Amer M.
    DEPRESSION AND ANXIETY, 2021, 38 (04) : 456 - 467
  • [37] Old and New Biomarkers for Infection, Inflammation, and Autoimmunity in Treatment-Resistant Affective and Schizophrenic Spectrum Disorders
    Scheiber, Christian
    Schulz, Tanja
    Schneider, Julian M.
    Bechter, Karl
    Schneider, E. Marion
    PHARMACEUTICALS, 2022, 15 (03)
  • [38] Pharmacokinetic and pharmacodynamic drug interactions with polypharmacotherapy of treatment-resistant affective and obsessive-compulsive disorders
    Carson, SW
    PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (04) : 555 - 568
  • [39] A Network Meta-Analysis of Clinical Management Strategies for Treatment-Resistant Hypertension: Making Optimal Use of the Evidence
    Makai, Peter
    IntHout, Joanna
    Deinum, Jaap
    Jenniskens, Kevin
    van der Wilt, Gert Jan
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 (08) : 921 - 930
  • [40] L-Tryptophan as an antidepressive agent in the management of treatment-resistant unipolar depression in borderline personality disorder: Three case reports
    Thomas, Stuart Richard
    ADVANCES IN INTEGRATIVE MEDICINE, 2015, 2 (01) : 68 - 71
12345